You would think that requires disclosure to the market. It seems something that might be more relevant to the CEO's departure than the CFO's. Reaper
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025